Clinical outcomes of patients with primary refractory metastatic renal cell carcinoma receiving second-line (2L) therapies: An International Metastatic Database Consortium (IMDC) study.
Journal Articles
-
- Overview
-
- Research
-
- Identity
-
- Additional Document Info
-
- View All
-
Overview
publication date
has subject area
published in
Research
keywords
-
32 Biomedical and Clinical Sciences
-
3202 Clinical Sciences
-
3211 Oncology and Carcinogenesis
-
Clinical Research
-
Kidney Disease
-
Orphan Drug
-
Rare Diseases
Identity
Digital Object Identifier (DOI)
Additional Document Info
start page
end page
volume
issue